Augmentin and Ultravist drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Ultravist (iopromide). Common drug interactions include confusional state among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin and Ultravist. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Ultravist?

Ultravist has active ingredients of iopromide. eHealthMe is studying from 9,246 Ultravist users. Check the latest studies of Ultravist.



On Jul, 10, 2026

18 people who take Augmentin and Ultravist together, and have interactions are studied.

Augmentin and Ultravist drug interactions.

What are the common drug interactions of Augmentin and Ultravist, by gender? *:

female:

  1. Confusional state
  2. Erythema (redness of the skin)
  3. Spinal compression fracture (fracture due to spinal compression on bone)
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  6. Renal failure acute (rapid kidney dysfunction)
  7. Alanine aminotransferase increased
  8. Aspartate aminotransferase increased
  9. Blood amylase increased
  10. Bloody discharge

male:

  1. Renal failure (kidney dysfunction)
  2. Acute respiratory distress syndrome
  3. Pulmonary alveolar haemorrhage (acute bleeding)
  4. Pulmonary oedema (fluid accumulation in the lungs)
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Tricuspid valve incompetence (inefficient heart valve)
  7. Ventricular dysfunction (heart dysfunction)
  8. Anal candidiasis (rectal fungal infection)
  9. Candidiasis (candidiasis or thrush is a fungal infection)
  10. Contrast media reaction (reaction associated with the use of intravenous contrast material during radiology)

What are the common drug interactions of Augmentin and Ultravist, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood amylase increased
  4. Lipase increased
  5. Pancreatitis (inflammation of pancreas)

40-49:

  1. Erythema (redness of the skin)

50-59:

  1. Chest discomfort
  2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  3. Loss of consciousness
  4. Panic attack
  5. Urinary incontinence (inability to control the flow of urine and involuntary urination)

60+:

  1. Renal failure (kidney dysfunction)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Oedema (fluid collection in tissue)
  4. Oliguria (not enough urine)
  5. Pulmonary alveolar haemorrhage (acute bleeding)
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Staphylococcal infection (an infection with staphylococcus bacteria)
  8. Tricuspid valve incompetence (inefficient heart valve)
  9. Ventricular dysfunction (heart dysfunction)
  10. Hyperkalaemia (damage to or disease of the kidney)

What are the existing conditions these people have? *

  1. Hepatic Neoplasm Malignant (liver cancer): 4 people, 22.22%
  2. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 11.11%
  3. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 11.11%
  4. Back Pain: 2 people, 11.11%
  5. Cholecystitis (infection of gallbladder): 2 people, 11.11%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.11%
  7. Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 2 people, 11.11%
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 11.11%
  9. Diarrhea: 2 people, 11.11%
  10. Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and Ultravist?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin and Ultravist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ultravist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultravist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and iopromide (the active ingredients of Augmentin and Ultravist, respectively), and Augmentin and Ultravist (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: